newsfilter
← Latest News
ACCESS Newswire·

Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity

PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 11, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of